If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
5,085.00    70.00 (1.40%)
Bid:
5,100.00
Ask:
5,105.00
Spread: 5.00 (0.098%)
Market Cap: £2.37b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Blocklisting Interim Review

26 Mar 2015 15:09

RNS Number : 6062I
Morgan Sindall Group PLC
26 March 2015
 



 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 26 March 2015

 

Name of applicant:

Morgan Sindall Group plc

Name of scheme:

Savings Related Option Scheme (SAYE Scheme)

Period of return:

From:

5 September 2014

To:

26 March 2015

Balance of unallotted securities under scheme(s) from previous return:

447,055 ordinary shares of 5p each.

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

750,000 ordinary shares in respect of the save as you earn scheme.

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

917,596 ordinary shares of 5p each.

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

279,459 ordinary shares of 5p each.

 

Name of contact:

Clare Sheridan, Company Secretary

Telephone number of contact:

020 7307 9200

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLREQLFLEXFBBBQ
Date   Source Headline
9th Jan 20207:00 amRNSNotice of Results
7th Jan 20204:39 pmRNSHolding(s) in Company
2nd Jan 20208:30 amRNSTotal Voting Rights
21st Nov 20199:21 amRNSDirector/PDMR Shareholding
20th Nov 201911:43 amRNSAdditional Listing
18th Nov 20199:48 amRNSAppointment to c£650m Slough scheme
18th Nov 20197:00 amRNSSenior Management Forum
11th Nov 201912:05 pmRNSHolding(s) in Company
11th Nov 201910:25 amRNSDirector/PDMR Shareholding
6th Nov 20197:00 amRNSTrading Update
1st Nov 20191:58 pmRNSTotal Voting Rights
21st Oct 201910:07 amRNSBlock listing Interim Review
8th Oct 20194:37 pmRNSPrice Monitoring Extension
2nd Oct 20194:08 pmRNSHolding(s) in Company
1st Oct 201910:19 amRNSTotal Voting Rights
3rd Sep 201911:30 amRNSAdditional Listing
2nd Sep 20192:49 pmRNSTotal Voting Rights
13th Aug 20193:34 pmRNSHolding(s) in Company
7th Aug 20197:00 amRNSHalf-year Report
1st Aug 201910:08 amRNSTotal Voting Rights
30th Jul 20194:44 pmRNSHolding(s) in Company
9th Jul 20197:00 amRNSNotice of Results
1st Jul 201910:20 amRNSTotal Voting Rights
24th Jun 20194:05 pmRNSHolding(s) in Company
31st May 20193:13 pmRNSHolding(s) in Company
31st May 20199:33 amRNSTotal Voting Rights
22nd May 20199:23 amRNSDirector Declaration
16th May 20198:30 amRNSAdditional Listing
9th May 201910:11 amRNSAwarded £1.6bn Sellafield contract
8th May 201912:21 pmRNSResult of AGM
8th May 20197:00 amRNSAGM Trading Update
1st May 201912:26 pmRNSTotal Voting Rights
23rd Apr 201912:05 pmRNSBlock listing Interim Review
1st Apr 201910:03 amRNSTotal Voting Rights
22nd Mar 20197:00 amRNSMorgan Sindall Group announces £1bn joint venture
21st Mar 201911:38 amRNSAnnual Financial Report
14th Mar 20193:36 pmRNSAdditional Listing - Amendment
14th Mar 20198:00 amRNSAdditional Listing
5th Mar 20194:03 pmRNSHolding(s) in Company
4th Mar 20193:19 pmRNSDirector/PDMR Shareholding
4th Mar 20193:13 pmRNSDirector/PDMR Shareholding
4th Mar 20193:10 pmRNSDirector/PDMR Shareholding
1st Mar 20191:58 pmRNSTotal Voting Rights
21st Feb 20197:00 amRNSFinal Results
1st Feb 201910:28 amRNSTotal Voting Rights
10th Jan 20193:37 pmRNSHolding(s) in Company
9th Jan 20197:00 amRNSNotice of Results
3rd Jan 20192:04 pmRNSTotal Voting Rights
19th Dec 201810:54 amRNSDirector Declaration
3rd Dec 20184:37 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.